Europe PMCopen access
Repurposing FDA-approved drugs as multi-target neuroprotective agents for Alzheimer's disease via computational screening and experimental validation
Alzheimer’s disease, Virtual Screening, Drug Repurposing, Bace1 Inhibitors, Multi-target Therapy
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 5503
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.